Live Feedback to Increase Adherence in Adolescents With Patellofemoral Pain

November 16, 2016 updated by: Michael Skovdal Rathleff, Aalborg University

Efficacy of Live Feedback to Increase Objectively Monitored Adherence to Prescribed, Home-based, Exercise Therapy-dosage in 15 to 19 Year Old Adolescents With Patellofemoral Pain. A Randomized Controlled Superiority Trial

This study investigates if live feedback during home-based exercises will improve the ability to perform the exercises with the prescribed time under tension (TUT) per repetition compared with no feedback among adolescents with patellofemoral pain. The hypothesis is that adolescents who receive live feedback from BandCizer™ will have a mean TUT that is significantly closer to the prescribed TUT compared to the group not receiving feedback during the course of the intervention.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • The North Denmark Region
      • Aalborg, The North Denmark Region, Denmark, 9000
        • Aalborg Universitetshospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 15 to 19 years of age
  • Anterior knee pain of non-traumatic origin which is provoked by at least two of the following activities: prolonged sitting with bended knees or kneeling, squatting, running, jumping or ascending or descending stairs
  • Tenderness on palpation of the peripatellar borders
  • Pain of more than 6 weeks duration
  • Worst pain during the previous week ≥ 30 mm on a 100 mm VAS

Exclusion Criteria:

  • Concomitant pain from other structures in the knee (e.g. ligament, tendon or cartilage), the hip or the lumbar spine
  • Previous knee surgery
  • Patellofemoral instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feedback group
Receives live feedback on TUT and pulling force during exercises.
Access to live visual and auditory feedback on TUT and pulling force from an application on an iPad.
3 exercises (knee extension, hip abduction and hip extension) using an elastic band with 3 sets of 10 repetitions at 10-12 RM 3 times a week for 6 weeks.
Active Comparator: Control group
Receives no feedback on TUT but on pulling force during exercises.
3 exercises (knee extension, hip abduction and hip extension) using an elastic band with 3 sets of 10 repetitions at 10-12 RM 3 times a week for 6 weeks.
Access only to live visual feedback on pulling force from an application on an iPad.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean deviation from the prescribed TUT per repetition in seconds during the course of the intervention
Time Frame: From 0-6 weeks
The mean deviation is calculated as the difference between actual TUT and prescribed TUT (8 seconds). E.g. if the actual TUT is 6.5 seconds, the deviation is 1.5 seconds
From 0-6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total number of repetitions performed
Time Frame: From 0-6 weeks
From 0-6 weeks
Pulling force exerted per repetition measured in kilos
Time Frame: From 0-6 weeks
This will be expressed as the maximum pulling force during each repetition
From 0-6 weeks
Isometric strength
Time Frame: At baseline and at the 6 week follow up
Presented as Nm/kg in x, y and z direction
At baseline and at the 6 week follow up
Pain measured on a 100 mm VAS
Time Frame: From 0-6 weeks
Is entered into the app by the adolescent before and after each exercise
From 0-6 weeks
Kujala Patellofemoral Scale-score
Time Frame: At baseline and at the 6 week follow up
Gives a score on patellofemoral pain ranging from 0 to 100 with 0 as complete disability and 100 as fully functional
At baseline and at the 6 week follow up
Global rating of change
Time Frame: At the 6 week follow up
Self-reported recovery on a 7-point Likert scale ranging from "much improved" to "much worse"
At the 6 week follow up
Summary of resistance
Time Frame: From 0-6 weeks
Total pulling force exerted during the course of the intervention measured in kilos
From 0-6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael S Rathleff, Ph.d., Aalborg University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

February 1, 2016

First Submitted That Met QC Criteria

February 4, 2016

First Posted (Estimate)

February 5, 2016

Study Record Updates

Last Update Posted (Estimate)

November 17, 2016

Last Update Submitted That Met QC Criteria

November 16, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

No later than 1 year after the final follow-up, a completely anonymised data set to an appropriate data archive for sharing purposes will be delivered.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Joint Diseases

Clinical Trials on Feedback on TUT

3
Subscribe